Navigation Links
Denosumab delayed time to first skeletal-related side effect
Date:12/10/2010

SAN ANTONIO For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.

"The average life expectancy of patients with metastatic breast cancer is approximately 2.5 years, so if you can prolong the time without a skeletal-related event by five months, you are substantially benefiting the patient," said Alison T. Stopeck, M.D., associate professor of medicine and director of the Clinical Breast Cancer Program at the Arizona Cancer Center, University of Arizona, Tucson.

The Food and Drug Administration approved denosumab, sold by Amgen as XGEVA starting Nov. 18, 2010, for the prevention of skeletal-related events in patients with bone metastases from solid tumors.

Previous results from this Phase III trial indicated that denosumab was superior to zoledronic acid in delaying the time to first on-study, skeletal-related side effects, such as fracture, radiation to bone, surgery to bone or spinal cord compression in patients with breast cancer and bone metastases. These results detail an additional four months of blinded treatment.

Stopeck and colleagues randomized 2,046 patients with advanced breast cancer to receive either 120 mg of subcutaneous denosumab or 4 mg of intravenous zoledronic acid every four weeks. Both of these drugs inhibit osteoclasts, or the cells that break down bone, therefore, all patients took calcium and vitamin D daily.

Denosumab was better at delaying the time to first on-study, skeletal-related event by 18 percent and the time to first and subsequent event by 22 percent. The median time to first on-study, skeletal-related event was five months longer for the denosumab group compared to the zoledronic acid group.

Overall survival and disease progression was similar for both grou
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pain Relief Often Delayed for Cancer Patients
2. Delayed retirement among Americans may bolster future of Social Security and Medicare, study finds
3. $18.5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C-Section
4. New study confirms positive effects of delayed school start times
5. For HIV-positive patients, delayed treatment a costly decision
6. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
7. Retired Military Brass Support First Ladys Call to Reduce Child Obesity, Improve Nutrition
8. NASBE Supports First Lady Michelle Obama in Fight Against Childhood Obesity
9. PolicyLink CEO Angela Glover Blackwell Released the Following Statement on First Lady Michelle Obamas Childhood Obesity Initiative
10. MSU launches first anti-counterfeiting research program
11. AMA Joins First Lady in Fight Against Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, Inc., a ... its medical management team as an Associate Medical Director. , WorkCare specializes ... in the U.S. and abroad. , Dr. Nelson has a diverse background. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s most respected chefs ... and dining. , Recently named “the next big thing” in the culinary world ... telling the whole story behind food and reclaiming culinary traditions on the brink of ...
(Date:9/1/2015)... ... , ... SC&H Group, a leading audit, tax, and consulting firm, received multiple ... Best” firm in the U.S., as well as being ranked a Top 100 Accounting ... U.S., selected exclusively on performance in specific areas of financial and operational management. ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... is now available. With the Connectivity Kit, EasySampler data is automatically transferred ... reactor control experiment, on a touchscreen platform. , EasySampler fully automates the ...
(Date:9/1/2015)... OH (PRWEB) , ... September 01, 2015 , ... Mercy ... – has devoted the 10th of its monthly Mercy Health: Helping You Be Well ... affecting one in seven men. , In a concise video on Mercy Health’s ...
Breaking Medicine News(10 mins):Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2
... workout may metabolize more fat than exercising without stopping, according ... conducted the first known study to compare these two exercise ... same workout with a rest period. The findings could change ... a breather for that" ,Many people believe prolonged ...
... to come up with the first ever legislation aimed at ... joining the workforce of its booming economy. ,A ... next month aims to put an end to everything from ... by some as too flimsy and by others as open ...
... the wheels of retail-based medical clinics. Accordingly, they will ... these clinics . They vouch that the move could ... to expand basic medical services. ,The proposed ... Caremark Corp. to open a retail clinic, MinuteClinic, in ...
... swim only to be struck by flesh-eating bacteria . ... of losing a life, possibly even his life. ... disease caused by a bacterium called Vibrio vulnificus. The ... multiple organ failure because the disease has caused a ...
... for his decision to boycott cancer charities that test on ... cancer charities since his first wife Linda died of the ... decline financial support to organisations that practice vivisection. ... a number of charities close to his heart promote the ...
... behind the detention of Indian doctor Mohammed Haneef is still ... are emerging to show that the police had proceeded on ... bail application last Saturday, Commonwealth Prosecutor Clive Porritt alleged the ... given his SIM card to his cousin Sabeel Ahmed. ...
Cached Medicine News:Health News:Take a Break Inbetween Exercise 2Health News:Take a Break Inbetween Exercise 3Health News:India Grapples With First Bill to Stop Workplace Sex Harassment 2Health News:Retail Health Clinics Start Shop 2Health News:Texan Battles Flesh-eating Bacteria Contracted While Swimming 2Health News:Haneefs SIM Card Not Recovered from the Burning Jeep 2
(Date:8/31/2015)... Aug. 31, 2015  Chiasma, Inc. (NASDAQ: ... octreotide capsules for the orphan condition acromegaly, today ... June 30, 2015 and provided a corporate update. ... a transformative time for Chiasma, as we successfully ... that our first New Drug Application (NDA) has ...
(Date:8/31/2015)... 2015 A new Transparency ... monitoring and diagnostic devices market stood at US$3.7 ... a value of approximately US$7.0 billion in 2019, ... and 2019. The title of the report is ... Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, Implantable Loop ...
(Date:8/31/2015)... YORK , Aug. 31, 2015  Dipexium Pharmaceuticals, ... focused on the development and commercialization of Locilex® (pexiganan ... today announced plans to participate in four investor conferences ... 2, 2015 at the Sidoti & Company, LLC Emerging ... . David P. Luci , President & ...
Breaking Medicine Technology:Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3
... announces the appointment of Susan C. Stansfield, PhD ... Development. In this position, Dr. Stansfield will have ... clinical trial management services provided to the biopharmaceutical ... proven leadership skills will be pivotal in enhancing ...
... Reportlinker.com announces that a new market research ... E7: The Outlook for Pharmaceuticals to ... The emerging E7 countries represent the ... these countries is huge: they have a ...
Cached Medicine Technology:Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development 2E7: The Outlook for Pharmaceuticals to 2012 2E7: The Outlook for Pharmaceuticals to 2012 3E7: The Outlook for Pharmaceuticals to 2012 4E7: The Outlook for Pharmaceuticals to 2012 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: